0001209191-11-023619.txt : 20110420
0001209191-11-023619.hdr.sgml : 20110420
20110420141031
ACCESSION NUMBER: 0001209191-11-023619
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20110413
FILED AS OF DATE: 20110420
DATE AS OF CHANGE: 20110420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hart Danny J Jr.
CENTRAL INDEX KEY: 0001518546
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 11770306
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BOULEVARD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
3
1
doc3.xml
FORM 3 SUBMISSION
X0203
3
2011-04-13
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001518546
Hart Danny J Jr.
932 SOUTHWOOD BOULEVARD
INCLINE VILLAGE
NV
89451
0
1
0
0
Assoc Genl Counsel/Asst Sec
Common Stock
2000
D
/s/ Danny J Hart, Jr.
2011-04-18
EX-24.3_374407
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints Christine R. Larson and
Christopher Stone, and each of them, his or her, true and lawful
attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary or appropriate
to obtain codes and passwords enabling the undersigned to make electronic
filings with the SEC of reports required by Section 16(a) of the Securities
Exchange Act of 1934 or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director, and/or person who holds more than 10% of the
stock of PDL BioPharma, Inc. (the "Company"), Forms 3, 4 and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5,
complete and execute any amendment(s) thereto, and timely file any such form
with the United States Securities and Exchange Commission and any stock exchange
or similar authority; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done pursuant to this power of attorney. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked or modified by the undersigned in a signed writing, but
shall terminate automatically as to each individual attorney-in-fact when such
person is no longer an employee of the Company. This Power of Attorney may be
filed with the SEC as a confirming statement of the authority granted herein.
The undersigned has caused this Power of Attorney to be executed as of this
18th day of April, 2011.
By: /s/ Danny J Hart, Jr.
Printed Name: Danny J Hart, Jr.